Advertisement
Post hoc analysis of PROTECTED TAVR finds reduced stroke risk in the U.S. but not beyond
Large longitudinal study supports earlier intervention over clinical surveillance
Analysis of STS/ACC TVT Registry finds greatest benefit in patients with prior stroke
Join us in New York Dec. 6-7 for broadened version of a CME crowd-pleaser
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Questions remain following late mortality signal from a retrospective cohort study
TAVR explant demands multidisciplinary expertise
Judicious application yields a 99.7% repair rate and 0.04% mortality
Limited data and experience will translate to a cautious rollout
Cleveland Clinic series supports re-repair as a favored option regardless of failure timing
Large retrospective study supports its addition to BAV repair toolbox at expert centers
Advertisement
Advertisement